Related Experiment Videos

Innovative DNA vaccine to break immune tolerance against tumor self-antigen

Tae Heung Kang1, Chih-Ping Mao, Victor La

  • 1Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.

Human Gene Therapy
|December 28, 2012
PubMed

Insights

This study introduces a novel DNA vaccine strategy that overcomes immune tolerance to cancer self-antigens. The engineered vaccine effectively activates T cells, leading to successful therapeutic outcomes in preclinical melanoma models.

Area of Science:

  • Immunology
  • Oncology
  • Vaccine Development

Background:

  • Cancer vaccination faces challenges due to immune tolerance to tumor self-antigens.
  • Developing effective cancer immunotherapies requires overcoming this immune evasion.

Purpose of the Study:

  • To describe a DNA vaccination strategy capable of overcoming immune tolerance to tumor self-antigen.
  • To evaluate the efficacy of a novel DNA vaccine in a preclinical cancer model.

Main Methods:

  • Engineered a DNA construct encoding a chimeric protein (SCT-Ag/IgG) comprising MHC class I heavy chain, β2-microglobulin, and peptide antigen linked to IgG.
  • Assessed the chimeric protein's ability to bind and activate antigen-specific CD8(+) T cells.
  • Investigated the coating of antigen-presenting cells and subsequent T cell activation.
  • Performed intradermal vaccination in a preclinical model of metastatic melanoma.

Main Results:

  • The chimeric protein efficiently bound and activated antigen-specific CD8(+) T cells.
  • Antigen-presenting cells coated with the chimeric protein effectively activated T cells.
  • DNA vaccination generated significant cytotoxic effector T cells against tumor self-antigen.
  • Achieved successful therapeutic outcomes in a preclinical melanoma model.

Conclusions:

  • The described DNA vaccine strategy breaks immune tolerance to melanoma-associated antigens.
  • This approach demonstrates potent therapeutic antitumor effects.
  • The strategy holds potential for controlling other cancers and infections.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
867
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
2.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.2K